tirzepatide chronic kidney disease trial reduces albuminuria among adults with type 2 diabetes in SURPASS trials Repurposing Diabetes Therapies in CKD:
Pay in 4 interest-free payments of $5.67 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11



00032-X/asset/f312f4e3-50d1-472f-90c9-896e4cef8e23/main.assets/gr1_lrg.jpg)


![3rd GLP-1-Based Therapeutics Summit 2026 [04/14/26]](https://media.thebostoncalendar.com/images/q_auto,fl_lossy/v1764586403/xfhrsgzqsy7gc1nv7hdi/3rd-glp-1-based-therapeutics-summit-2026.jpg)
![2nd GLP-1-Based Therapeutics Summit 2025 [04/29/25]](https://media.thebostoncalendar.com/images/q_auto,fl_lossy/v1738219627/pjmw3upta2sablq6vpmq/2nd-glp-1-based-therapeutics-summit-2025.jpg)

















